MedPath

efficacy of memantine on opioid substances withdrawal symptoms

Phase 3
Recruiting
Conditions
Opioid use disorder.
Opioid related disorders
Registration Number
IRCT20090801002266N11
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Consent to participate in the study
DSM-IV criteria for drug dependence
Regular and daily use of opium orally, injectable or smoke

Exclusion Criteria

Non-use of psychiatric drugs and other substances other than cigarettes
Taking pain medications
Comorbid of major psychiatric disorders
Physical illness that is a prohibition on quitting drugs.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath